These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 23856648)

  • 1. Perfusion studies in senology.
    de Bazelaire C; Scémama A; Coffin A; Cohen S; Chapellier M; Sabatier F; Albiter M; de Kerviler E
    Diagn Interv Imaging; 2013 Dec; 94(12):1279-90. PubMed ID: 23856648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CT and MRI imaging in tumoral angiogenesis].
    de Bazelaire C; Calmon R; Chapellier M; Pluvinage A; Frija J; de Kerviler E
    Bull Cancer; 2010 Jan; 97(1):79-90. PubMed ID: 19858045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Utility of MRI contrast agents for diagnosis and treatment follow-up in cancer].
    Siauve N; Clément O
    Bull Cancer; 2007 Feb; 94(2):139-46. PubMed ID: 17337383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI.
    Cuenod CA; Balvay D
    Diagn Interv Imaging; 2013 Dec; 94(12):1187-204. PubMed ID: 24211260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series.
    Brix G; Kiessling F; Lucht R; Darai S; Wasser K; Delorme S; Griebel J
    Magn Reson Med; 2004 Aug; 52(2):420-9. PubMed ID: 15282828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
    Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E
    Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry.
    Vincensini D; Dedieu V; Eliat PA; Vincent C; Bailly C; de Certaines J; Joffre F
    Magn Reson Imaging; 2007 Apr; 25(3):293-302. PubMed ID: 17371717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MRI features of space-occupying lesions in the breast].
    Serebriakova SV; Trufanov GE; Fokin VA; Iukhno EA; Tikhova KE; Iakovleva EK
    Vopr Onkol; 2011; 57(1):92-8. PubMed ID: 21598716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of breast cancer angiogenesis: a review.
    Furman-Haran E; Kelcz F; Degani H
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):47-54. PubMed ID: 12585654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the microcirculation: advances in cardiac magnetic resonance perfusion imaging.
    Patel AR; Epstein FH; Kramer CM
    J Nucl Cardiol; 2008; 15(5):698-708. PubMed ID: 18761273
    [No Abstract]   [Full Text] [Related]  

  • 12. Parametric imaging of tumor perfusion using flow- and permeability-limited tracers.
    Bogin L; Margalit R; Mispelter J; Degani H
    J Magn Reson Imaging; 2002 Sep; 16(3):289-99. PubMed ID: 12205585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A physiologic model of capillary-tissue exchange for dynamic contrast-enhanced imaging of tumor microcirculation.
    Koh TS; Cheong LH; Hou Z; Soh YC
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):159-67. PubMed ID: 12665029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data.
    Makkat S; Luypaert R; Sourbron S; Stadnik T; De Mey J
    J Magn Reson Imaging; 2007 Jun; 25(6):1159-67. PubMed ID: 17520720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perfusion by magnetic resonance imaging: its physical foundations and clinical application].
    Fayed-Miguel N; Castillo-Blandino J; Medrano-Lin J
    Rev Neurol; 2010 Jan 1-15; 50(1):23-32. PubMed ID: 20073020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
    Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in breast MRI and MRS.
    Sinha S; Sinha U
    NMR Biomed; 2009 Jan; 22(1):3-16. PubMed ID: 18654998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood oxygenation level-dependent (BOLD) contrast magnetic resonance imaging (MRI) for prediction of breast cancer chemotherapy response: a pilot study.
    Jiang L; Weatherall PT; McColl RW; Tripathy D; Mason RP
    J Magn Reson Imaging; 2013 May; 37(5):1083-92. PubMed ID: 23124705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser speckle contrast imaging for assessment of liver microcirculation.
    Sturesson C; Milstein DM; Post IC; Maas AM; van Gulik TM
    Microvasc Res; 2013 May; 87():34-40. PubMed ID: 23403398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis.
    Heldahl MG; Bathen TF; Rydland J; Kvistad KA; Lundgren S; Gribbestad IS; Goa PE
    Acta Radiol; 2010 Jul; 51(6):604-12. PubMed ID: 20429756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.